[
  {
    "ts": null,
    "headline": "Here’s Why Dexcom (DXCM) Traded Down in Q3",
    "summary": "Sands Capital, an investment management company, released its “Sands Capital Select Growth Strategy” Q3 2025 investor letter. A copy of the letter can be downloaded here. U.S. large-cap growth equities continued to recover from a sharp sell-off in early April. Strong corporate earnings, investor enthusiasm around artificial intelligence (AI), and growing expectations for Federal Reserve […]",
    "url": "https://finnhub.io/api/news?id=55383515109c05d7ec3c5d15edf0c5bf3437ead96d0b32fd4e91e379a094fd1c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764249181,
      "headline": "Here’s Why Dexcom (DXCM) Traded Down in Q3",
      "id": 137620964,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Sands Capital, an investment management company, released its “Sands Capital Select Growth Strategy” Q3 2025 investor letter. A copy of the letter can be downloaded here. U.S. large-cap growth equities continued to recover from a sharp sell-off in early April. Strong corporate earnings, investor enthusiasm around artificial intelligence (AI), and growing expectations for Federal Reserve […]",
      "url": "https://finnhub.io/api/news?id=55383515109c05d7ec3c5d15edf0c5bf3437ead96d0b32fd4e91e379a094fd1c"
    }
  }
]